ARCT, BITF and FRE are among premarket gainers
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 28 2024
0mins
Source: SeekingAlpha
- Insmed (INSM) surged by 141% due to a late-stage win for lung disease therapy.
- Calliditas Therapeutics (CALT) saw a 71% increase after an offer to buy Calliditas Therapeutics for $1.1 billion.
- Predictive Oncology (POAI) rose by 58% following positive results from an ovarian cancer study with UPMC Magee-Womens Hospital.
- Agios Pharmaceuticals (AGIO) increased by 23% as it entered a pact with Royalty Pharma for a brain tumor candidate.
- Gamestop Corporation (GME) resumed its meme-fueled rally with a 24% increase after completing an offering.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CISS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CISS
About CISS
C3is Inc. is a Greece-based entity, incorporated in Marshall Islands, primarily engaged in seaborne transportation services to drybulk charterer for both national and private clients. The Company acts as a holding company and operates through its two subsidiaries. The Company's fleet consists of two handysize drybulk carriers: Eco Bushfire and Eco Angelbay.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
C3is Inc. Stock Soars After Reverse Split Implementation
- Reverse Split Implementation: C3is Inc. executed a 1-for-20 reverse stock split on Sunday, leading to a 15.59% surge in after-hours trading to $2.15, despite a 9.71% drop to $1.86 during regular trading, indicating initial market reaction to the split.
- Share Count Reduction: The reverse split reduced outstanding shares from approximately 24.7 million to 1.23 million, with no fractional shares issued, and shareholders compensated in cash, aimed at enhancing per-share value and attracting investor interest.
- Warrant Adjustments: The company’s outstanding warrants and Series A Convertible Preferred Stock will be proportionately adjusted to reflect the reverse split, ensuring investor rights are preserved and potentially boosting market confidence.
- Market Performance Analysis: C3is Inc. has a Relative Strength Index (RSI) of 19.67 and a market capitalization of $1.91 million, with a staggering 98.71% decline in stock price over the past 12 months, currently positioned near its 52-week low, reflecting significant loss of investor confidence.
Continue Reading
C3is (CISS) Acquires Two Medium Range Tankers for $39.8 Million, Expanding Fleet by 50%
- Acquisition Announcement: C3is has agreed to acquire two medium range product tankers for a total of $39.8 million, with one tanker priced at $16.88 million and the other at $22.90 million, expected to be delivered between Q1 and Q3 of 2026, thereby expanding its fleet by 50%.
- Fleet Expansion: Following the acquisitions, C3is will increase its fleet to six vessels, comprising three Handysize dry bulk carriers and three tankers, including an Aframax oil tanker, which enhances the company's competitive position in the shipping market.
- Funding Source: The company stated that the acquisitions will be financed through a one-year interest-free loan, ensuring financial flexibility and cost control for the transactions.
- Board Approval: The deals have been approved by C3is's independent directors, reflecting the company's commitment to governance transparency and shareholder interests.
Continue Reading